IGM Biosciences Inc. Faces Nasdaq Delisting Risk Due to Non-Compliance with $50M Market Value Requirement

Reuters

06-12

<a href="https://laohu8.com/S/IGMS">IGM Biosciences</a> Inc. Faces Nasdaq Delisting Risk Due to Non-Compliance with $50M Market Value Requirement

IGM Biosciences Inc. has announced that it has received a notice from The Nasdaq Stock Market LLC indicating non-compliance with the minimum Market Value of Listed Securities (MVLS) of 50 million, a requirement for continued listing on The Nasdaq Global Select Market. As per the Nasdaq Listing Rule 5450(b)(A)$, the company must regain compliance by December 3, 2025, which entails maintaining an MVLS of at least $50 million for 10 consecutive business days. Currently, IGM Biosciences' common stock continues to trade under the symbol "IGMS." The company is exploring options to address this issue, which may include transferring its listing to The Nasdaq Capital Market. If compliance is not restored by the deadline, the company faces potential delisting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IGM Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-084924), on June 11, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2542530124"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2542530124\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2542530124?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-12 05:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2542530124","market":"us","top_or_hot":-1,"title":"IGM Biosciences Inc. Faces Nasdaq Delisting Risk Due to Non-Compliance with $50M Market Value Requirement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/IGMS\">IGM Biosciences</a> Inc. Faces Nasdaq Delisting Risk Due to Non-Compliance with $50M Market Value Requirement\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        IGM Biosciences Inc. has announced that it has received a notice from The Nasdaq Stock Market LLC indicating non-compliance with the minimum Market Value of Listed Securities (MVLS) of <a href=\"https://laohu8.com/S/2\">50 million, a requirement for continued listing on The Nasdaq Global Select Market. As per the Nasdaq Listing Rule 5450(b)</a>(A)$, the company must regain compliance by December 3, 2025, which entails maintaining an MVLS of at least $50 million for 10 consecutive business days. Currently, IGM Biosciences' common stock continues to trade under the symbol \"IGMS.\" The company is exploring options to address this issue, which may include transferring its listing to The Nasdaq Capital Market. If compliance is not restored by the deadline, the company faces potential delisting.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IGM Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-084924), on June 11, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IGM Biosciences Inc. Faces Nasdaq Delisting Risk Due to Non-Compliance with $50M Market Value Requirement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIGM Biosciences Inc. Faces Nasdaq Delisting Risk Due to Non-Compliance with $50M Market Value Requirement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-12 05:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/IGMS\">IGM Biosciences</a> Inc. Faces Nasdaq Delisting Risk Due to Non-Compliance with $50M Market Value Requirement\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        IGM Biosciences Inc. has announced that it has received a notice from The Nasdaq Stock Market LLC indicating non-compliance with the minimum Market Value of Listed Securities (MVLS) of <a href=\"https://laohu8.com/S/2\">50 million, a requirement for continued listing on The Nasdaq Global Select Market. As per the Nasdaq Listing Rule 5450(b)</a>(A)$, the company must regain compliance by December 3, 2025, which entails maintaining an MVLS of at least $50 million for 10 consecutive business days. Currently, IGM Biosciences' common stock continues to trade under the symbol \"IGMS.\" The company is exploring options to address this issue, which may include transferring its listing to The Nasdaq Capital Market. If compliance is not restored by the deadline, the company faces potential delisting.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IGM Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-084924), on June 11, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IGMS","symbol_name":"IGM Biosciences","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL3wVCM5:1","article_id":"2542530124","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2542530124","pubTimestamp":1749676110,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"IGM Biosciences Inc. has announced that it has received a notice from The Nasdaq Stock Market LLC indicating non-compliance with the minimum Market Value of Listed Securities  of $50 million, a requirement for continued listing on The Nasdaq Global Select Market. As per the Nasdaq Listing Rule 5450, the company must regain compliance by December 3, 2025, which entails maintaining an MVLS of at least $50 million for 10 consecutive business days. Currently, IGM Biosciences' common stock continues to trade under the symbol \"IGMS.\" The company is exploring options to address this issue, which may include transferring its listing to The Nasdaq Capital Market. If compliance is not restored by the deadline, the company faces potential delisting.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IGMS":"IGM Biosciences","BK4505":"高瓴资本持仓","BK4139":"生物科技"},"translate_title":"IGM Biosciences Inc.因不符合5000万美元市值要求而面临纳斯达克退市风险","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IGMS":0.9},"content_text":"IGM Biosciences Inc. Faces Nasdaq Delisting Risk Due to Non-Compliance with $50M Market Value Requirement\n    \n\n        IGM Biosciences Inc. has announced that it has received a notice from The Nasdaq Stock Market LLC indicating non-compliance with the minimum Market Value of Listed Securities (MVLS) of 50 million, a requirement for continued listing on The Nasdaq Global Select Market. As per the Nasdaq Listing Rule 5450(b)(A)$, the company must regain compliance by December 3, 2025, which entails maintaining an MVLS of at least $50 million for 10 consecutive business days. Currently, IGM Biosciences' common stock continues to trade under the symbol \"IGMS.\" The company is exploring options to address this issue, which may include transferring its listing to The Nasdaq Capital Market. If compliance is not restored by the deadline, the company faces potential delisting.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IGM Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-084924), on June 11, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}